Galectin Therapeutics Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Norcross GA United States (2000)

Organization Overview

First Clinical Trial
2003
NCT00054977
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Consultant to Pro-Pharmaceuticals, Inc. | Galectin Therapeutics Inc. | Pro-Pharmaceuticals, Inc.